Martingale Asset Management L P reduced its stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,412 shares of the specialty chemicals company's stock after selling 11,056 shares during the period. Martingale Asset Management L P owned about 0.06% of Hawkins worth $1,523,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Blue Trust Inc. grew its stake in shares of Hawkins by 155.4% during the fourth quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company's stock worth $44,000 after buying an additional 216 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in Hawkins by 262.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 442 shares of the specialty chemicals company's stock worth $55,000 after purchasing an additional 320 shares in the last quarter. TD Private Client Wealth LLC raised its position in Hawkins by 242.5% in the third quarter. TD Private Client Wealth LLC now owns 459 shares of the specialty chemicals company's stock valued at $59,000 after purchasing an additional 325 shares during the last quarter. KBC Group NV boosted its stake in shares of Hawkins by 37.0% during the fourth quarter. KBC Group NV now owns 948 shares of the specialty chemicals company's stock valued at $116,000 after purchasing an additional 256 shares in the last quarter. Finally, Longboard Asset Management LP bought a new stake in shares of Hawkins during the fourth quarter worth about $212,000. 69.71% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of brokerages recently issued reports on HWKN. CJS Securities assumed coverage on shares of Hawkins in a report on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 price objective for the company. BWS Financial raised shares of Hawkins from a "neutral" rating to a "buy" rating and set a $160.00 price objective on the stock in a research note on Monday.
Check Out Our Latest Stock Report on Hawkins
Hawkins Trading Up 0.1 %
HWKN traded up $0.12 during trading on Thursday, hitting $121.34. The company's stock had a trading volume of 26,798 shares, compared to its average volume of 132,912. The firm has a market capitalization of $2.54 billion, a P/E ratio of 30.95, a PEG ratio of 3.80 and a beta of 0.82. Hawkins, Inc. has a twelve month low of $71.98 and a twelve month high of $139.55. The stock's fifty day moving average price is $108.09 and its 200-day moving average price is $117.80. The company has a quick ratio of 1.53, a current ratio of 2.50 and a debt-to-equity ratio of 0.23.
Hawkins (NASDAQ:HWKN - Get Free Report) last released its earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.77 by ($0.05). Hawkins had a net margin of 8.60% and a return on equity of 18.95%. Analysts anticipate that Hawkins, Inc. will post 4 EPS for the current year.
Hawkins Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date of this dividend was Friday, February 14th. Hawkins's payout ratio is 18.37%.
About Hawkins
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Further Reading

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.